EraCal Therapeutics AG’s €235 Million Licensing Agreement To Novo Nordisk

VISCHER advised EraCal on all legal issues related to the transaction.EraCal Therapeutics has signed a collaboration and license agreement with Danish pharma producer Novo Nordisk. According…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Marco Zingaro

This content is for Standard 1 Year members only.
Login Join Now